An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...

A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...

Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival rates. The vaccine was tested in a phase 1 trial involving 20 pancreatic ...

A new experimental pancreatic cancer vaccine may help stop the disease from coming back. it targets common gene mutations found in about 90% of pancreatic cancers.

Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...

The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

The Clean Label Project tested store-bought coffee and found it is mostly free of harmful levels of toxins and contaminants, ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.